WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma

Glioblastoma (GBM) is a universally fatal brain cancer, for which novel therapies targeting specific underlying oncogenic events are urgently needed. While the WNT pathway has been shown to be frequently activated in GBM, constituting a potential therapeutic target, the relevance of WNT6, an activat...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Theranostics
Autori principali: Gonçalves, Céline S., Vieira de Castro, Joana, Pojo, Marta, Martins, Eduarda P., Queirós, Sandro, Chautard, Emmanuel, Taipa, Ricardo, Pires, Manuel Melo, Pinto, Afonso A., Pardal, Fernando, Custódia, Carlos, Faria, Cláudia C., Clara, Carlos, Reis, Rui M., Sousa, Nuno, Costa, Bruno M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Ivyspring International Publisher 2018
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6160775/
https://ncbi.nlm.nih.gov/pubmed/30279739
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.25025
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi